Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Karl Michalko

Hand Surgery Rochester, NY Medical Doctor

NPI 1386686947 CMS profile 334549

360 Linden Oaks, Suite 210, Rochester, NY 14625

Open in the dashboard

General payments

$1,500

18 records reported · program years 2019–2025

Research payments

$63

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Karl Michalko of Rochester, NY is reported in the CMS Open Payments database as having received $1,500 across 18 general payments and $63 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 42nd percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $418 3
2024 General $444 3
2023 General $66 1
2023 Research $63 1
2021 General $204 3
2020 General $68 1
2019 General $300 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Karl Michalko
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Karl Michalko were reported at $418. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Karl Michalko Hand Surgery median Middle half National median
2019 $300 $383 $106–$1,905 $163
2020 $68 $172 $51–$1,268 $114
2021 $204 $263 $71–$1,591 $132
2022 $0 $336 $87–$1,938 $149
2023 $66 $233 $81–$1,114 $160
2024 $444 $258 $88–$1,203 $164
2025 $418 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ensemble Orthopedics, Inc $419 3 payments
  2. Skeletal Dynamics Inc $357 3 payments
  3. AxoGen $155 1 payment
  4. Arthrosurface Incorporated $149 3 payments
  5. Arthrex, Inc. $105 3 payments
  6. Anika Therapeutics, Inc. $101 1 payment
  7. Flower Orthopedics Coporation $81 1 payment
  8. Checkpoint Surgical, Inc $66 1 payment
  9. Prodigy Surgical Distribution, Inc. $47 1 payment
  10. Integra LifeSciences Corporation $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,453 17 payments
  2. Education $47 1 payment
Products named General payments · program years 2019–2025
  1. Ensemble CMC $419 3 payments
  2. Geminus $357 3 payments
  3. Align $357 3 payments
  4. IJS $357 3 payments
  5. IMPlate $357 3 payments
  6. HemiCAP Wrist $121 2 payments
  7. SpeedSpiral $101 1 payment
  8. Checkpoint Stimulators $66 1 payment
  9. HemiCAP Shoulder $28 1 payment
  10. INTEGRA DERMAL REGENERATION TEMPLATE $22 1 payment
  11. Other $86 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Dunamis Medical, LLC $63 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

130

Median for Hand Surgery: 118

Drug cost

$701

Median for Hand Surgery: $615

Branded share of claims

100%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 110 $613
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 20 $88

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 42 billing codes

Paid by Medicare

$53,673

Of which drugs: $263

Medicare patients

159

Average age 73

Services billed

2,266

95 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Arthritis 72%
Diabetes 29%
Depression 23%
Ischemic heart disease 21%
Chronic kidney disease 20%
Atrial fibrillation 18%
COPD 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 69 1,758 $171
Injection, methylprednisolone acetate, 40 mg J1030 Office 22 30 $92

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

19 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record